FIELD: chemistry.
SUBSTANCE: described are novel derivatives of pyrazolo[1,5-a]pyrimidine with general formula 1 
(values of radicals are given in the formula of invention), a pharmaceutical composition containing said derivatives and use of the novel compounds for preparing a medicinal agent for treating one or more diseases associated with cyclin-dependant kinalse CDK2.
EFFECT: novel compounds have useful biological properties.
36 cl, 87 tbl, 607 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2428424C2 |
| NEW ANTIMICROBIAL AGENTS | 2009 |
|
RU2522582C2 |
| 3,4-DISUBSTITUTED CYCLOBUTENE-1,2-DIONES AS LIGANDS OF CXC-CHEMOKINE RECEPTOR | 2002 |
|
RU2344123C9 |
| PYRIDOPYRAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING OR PREVENTING PHYSIOLOGICAL AND/OR PATHOPHYSIOLOGICAL CONDITIONS BY INHIBITION OF ENZYMES ERK, ERK1, ERK2, PI3K, PI3Kalpha, PI3Kbeta, PI3Kgamma, PI3Kdelta, PI3K-C2alpha, PI3K-C2beta, PI3K-Vps34p (VERSIONS) | 2006 |
|
RU2515944C9 |
| COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2006 |
|
RU2424230C2 |
| HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | 2004 |
|
RU2405774C9 |
| TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
| CARBOCYCLIC AND HETEROCYCLIC ARYLSULFONES AS γ-SECRETASE INHIBITORS | 2007 |
|
RU2448964C2 |
| DERIVATIVES OF ORTHO-ANTRANILAMIDE AS ANTI-COAGULATING AGENTS, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT | 1998 |
|
RU2226529C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
